Cargando…

Determining Whether High Nodal Burden in Early Breast Cancer Patients Can Be Predicted Preoperatively to Avoid Sentinel Lymph Node Biopsy

PURPOSE: The Z0011 trial showed that axillary lymph node dissection (ALND) can be safely avoided in breast cancer patients with low nodal burden (LNB). ALND can be performed in patients with high nodal burden (HNB). We aimed to determine whether HNB in early breast cancer patients can be predicted p...

Descripción completa

Detalles Bibliográficos
Autores principales: Lim, Geok Hoon, Teo, Sze Yiun, Allen, John Carson, Chinthala, Jubal Pallavi, Leong, Lester Chee Hao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Breast Cancer Society 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6438828/
https://www.ncbi.nlm.nih.gov/pubmed/30941234
http://dx.doi.org/10.4048/jbc.2019.22.e8
_version_ 1783407152580263936
author Lim, Geok Hoon
Teo, Sze Yiun
Allen, John Carson
Chinthala, Jubal Pallavi
Leong, Lester Chee Hao
author_facet Lim, Geok Hoon
Teo, Sze Yiun
Allen, John Carson
Chinthala, Jubal Pallavi
Leong, Lester Chee Hao
author_sort Lim, Geok Hoon
collection PubMed
description PURPOSE: The Z0011 trial showed that axillary lymph node dissection (ALND) can be safely avoided in breast cancer patients with low nodal burden (LNB). ALND can be performed in patients with high nodal burden (HNB). We aimed to determine whether HNB in early breast cancer patients can be predicted preoperatively to avoid sentinel lymph node biopsy (SLNB). METHODS: Early invasive breast cancer patients (cT1-2cN0) were retrospectively reviewed. We excluded patients with neoadjuvant chemotherapy and incomplete data. The patients were divided into the following groups based on surgical histology: no positive (N0), LNB, and HNB, defined as 0, 1–2, and ≥ 3 metastatic lymph nodes (LNs), respectively. Of the patients with metastatic nodal disease, only those with ALND were included in the analysis. Clinical, radiological, and histological parameters were evaluated using logistic regression analysis as predictors of HNB versus LNB and N0 combined. RESULTS: Of the 1,298 included patients, 832 (64.1%), 286 (22.0%), and 180 (13.9%) had N0, LNB, and HNB, respectively. Univariate logistic regression analysis revealed that sonographic features of breast tumor size (p < 0.0001), number of abnormal LNs (p < 0.0001), cortical thickness (p = 0.0002), effacement of the fatty hilum (p < 0.0001), and needle biopsy being performed (p < 0.0001) were indicators of HNB. Breast tumor grade (p = 0.0001) and human epidermal growth factor receptor 2 status (p = 0.0262) were also statistically significant. Among these significant features, multivariable stepwise logistic regression showed that the number of abnormal LNs is the sole independent predictor of HNB (p < 0.0001, area under the curve = 0.774). The positive predictive value of HNB in patients with ≥ 4 abnormal LNs was 92.9%. CONCLUSION: The detection of ≥ 4 abnormal LNs on ultrasound can help to identify HNB patients who require upfront ALND and thus avoid SLNB.
format Online
Article
Text
id pubmed-6438828
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Korean Breast Cancer Society
record_format MEDLINE/PubMed
spelling pubmed-64388282019-04-02 Determining Whether High Nodal Burden in Early Breast Cancer Patients Can Be Predicted Preoperatively to Avoid Sentinel Lymph Node Biopsy Lim, Geok Hoon Teo, Sze Yiun Allen, John Carson Chinthala, Jubal Pallavi Leong, Lester Chee Hao J Breast Cancer Original Article PURPOSE: The Z0011 trial showed that axillary lymph node dissection (ALND) can be safely avoided in breast cancer patients with low nodal burden (LNB). ALND can be performed in patients with high nodal burden (HNB). We aimed to determine whether HNB in early breast cancer patients can be predicted preoperatively to avoid sentinel lymph node biopsy (SLNB). METHODS: Early invasive breast cancer patients (cT1-2cN0) were retrospectively reviewed. We excluded patients with neoadjuvant chemotherapy and incomplete data. The patients were divided into the following groups based on surgical histology: no positive (N0), LNB, and HNB, defined as 0, 1–2, and ≥ 3 metastatic lymph nodes (LNs), respectively. Of the patients with metastatic nodal disease, only those with ALND were included in the analysis. Clinical, radiological, and histological parameters were evaluated using logistic regression analysis as predictors of HNB versus LNB and N0 combined. RESULTS: Of the 1,298 included patients, 832 (64.1%), 286 (22.0%), and 180 (13.9%) had N0, LNB, and HNB, respectively. Univariate logistic regression analysis revealed that sonographic features of breast tumor size (p < 0.0001), number of abnormal LNs (p < 0.0001), cortical thickness (p = 0.0002), effacement of the fatty hilum (p < 0.0001), and needle biopsy being performed (p < 0.0001) were indicators of HNB. Breast tumor grade (p = 0.0001) and human epidermal growth factor receptor 2 status (p = 0.0262) were also statistically significant. Among these significant features, multivariable stepwise logistic regression showed that the number of abnormal LNs is the sole independent predictor of HNB (p < 0.0001, area under the curve = 0.774). The positive predictive value of HNB in patients with ≥ 4 abnormal LNs was 92.9%. CONCLUSION: The detection of ≥ 4 abnormal LNs on ultrasound can help to identify HNB patients who require upfront ALND and thus avoid SLNB. Korean Breast Cancer Society 2019-01-30 /pmc/articles/PMC6438828/ /pubmed/30941234 http://dx.doi.org/10.4048/jbc.2019.22.e8 Text en © 2019 Korean Breast Cancer Society https://creativecommons.org/licenses/by-nc/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (https://creativecommons.org/licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Article
Lim, Geok Hoon
Teo, Sze Yiun
Allen, John Carson
Chinthala, Jubal Pallavi
Leong, Lester Chee Hao
Determining Whether High Nodal Burden in Early Breast Cancer Patients Can Be Predicted Preoperatively to Avoid Sentinel Lymph Node Biopsy
title Determining Whether High Nodal Burden in Early Breast Cancer Patients Can Be Predicted Preoperatively to Avoid Sentinel Lymph Node Biopsy
title_full Determining Whether High Nodal Burden in Early Breast Cancer Patients Can Be Predicted Preoperatively to Avoid Sentinel Lymph Node Biopsy
title_fullStr Determining Whether High Nodal Burden in Early Breast Cancer Patients Can Be Predicted Preoperatively to Avoid Sentinel Lymph Node Biopsy
title_full_unstemmed Determining Whether High Nodal Burden in Early Breast Cancer Patients Can Be Predicted Preoperatively to Avoid Sentinel Lymph Node Biopsy
title_short Determining Whether High Nodal Burden in Early Breast Cancer Patients Can Be Predicted Preoperatively to Avoid Sentinel Lymph Node Biopsy
title_sort determining whether high nodal burden in early breast cancer patients can be predicted preoperatively to avoid sentinel lymph node biopsy
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6438828/
https://www.ncbi.nlm.nih.gov/pubmed/30941234
http://dx.doi.org/10.4048/jbc.2019.22.e8
work_keys_str_mv AT limgeokhoon determiningwhetherhighnodalburdeninearlybreastcancerpatientscanbepredictedpreoperativelytoavoidsentinellymphnodebiopsy
AT teoszeyiun determiningwhetherhighnodalburdeninearlybreastcancerpatientscanbepredictedpreoperativelytoavoidsentinellymphnodebiopsy
AT allenjohncarson determiningwhetherhighnodalburdeninearlybreastcancerpatientscanbepredictedpreoperativelytoavoidsentinellymphnodebiopsy
AT chinthalajubalpallavi determiningwhetherhighnodalburdeninearlybreastcancerpatientscanbepredictedpreoperativelytoavoidsentinellymphnodebiopsy
AT leonglestercheehao determiningwhetherhighnodalburdeninearlybreastcancerpatientscanbepredictedpreoperativelytoavoidsentinellymphnodebiopsy